PR Newswire11.02.16
Shareholder Rights Law Firm Johnson & Weaver, LLP has commenced an investigation of Zimmer Biomet Holdings, Inc. concerning possible violations of federal securities laws. Zimmer provides musculoskeletal healthcare products and solutions.
On October 31, 2016, Zimmer announced that it was reducing its full-year forecast for 2016 from a previous estimate of $7.71 billion; Zimmer now predicts revenues to be between $7.63 billion and $7.65 billion. On the news Zimmer shares closed down 14% on October 31, 2016.
If you have information that could assist in this investigation, including past employees and others, or if you are a Zimmer shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or phone at 619-814-4471. If emailing, please include a phone number where you can be reached.
On October 31, 2016, Zimmer announced that it was reducing its full-year forecast for 2016 from a previous estimate of $7.71 billion; Zimmer now predicts revenues to be between $7.63 billion and $7.65 billion. On the news Zimmer shares closed down 14% on October 31, 2016.
If you have information that could assist in this investigation, including past employees and others, or if you are a Zimmer shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or phone at 619-814-4471. If emailing, please include a phone number where you can be reached.